Cargando…

The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care

Objectives: To assess the use of three commonly prescribed psychotropic medications in youth placed in residential care (RC). Methods: Participants were youth aged 0–20 years placed in RC institutions at least once during 2016. Data on filled prescriptions were taken from the Norwegian Prescription...

Descripción completa

Detalles Bibliográficos
Autores principales: Oerbeck, Beate, Overgaard, Kristin Romvig, Hjellvik, Vidar, Lien, Lars, Bramness, Jørgen G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233215/
https://www.ncbi.nlm.nih.gov/pubmed/33635152
http://dx.doi.org/10.1089/cap.2020.0123
_version_ 1783713802370416640
author Oerbeck, Beate
Overgaard, Kristin Romvig
Hjellvik, Vidar
Lien, Lars
Bramness, Jørgen G
author_facet Oerbeck, Beate
Overgaard, Kristin Romvig
Hjellvik, Vidar
Lien, Lars
Bramness, Jørgen G
author_sort Oerbeck, Beate
collection PubMed
description Objectives: To assess the use of three commonly prescribed psychotropic medications in youth placed in residential care (RC). Methods: Participants were youth aged 0–20 years placed in RC institutions at least once during 2016. Data on filled prescriptions were taken from the Norwegian Prescription Database to compare the use of antidepressants, antipsychotics, and stimulants in RC with the age- and gender-adjusted general child population (GenPop) and how this co-varied with reasons for RC placement, age, and gender. Results: One thousand eight hundred fifty-six children and adolescents were identified in RC, with mean age 14 (range 0–20 years), 46% girls, 81% ≥ 13 years. Among those, 423 or 23% used any of the 3 psychotropics, which was significantly more than the 3.7% in GenPop. The prevalence ratios RC/GenPop were 6.6 for antidepressants, 17.9 for antipsychotics, and 4.4 for stimulants. The median number of days per year for the dispensed defined daily doses varied from 8.3 to 244.0 for the different antipsychotics, indicating short time use for most of the people. Polypharmacy was not frequent in RC, as only 26% used ≥2 classes of medication, but still significantly more frequent than the 10% in GenPop. Youth placed in RC for serious behavior problems had significantly higher use of stimulants than those with other placement reasons. Psychotropics were not used below age 6 years, and although the use of antidepressants and antipsychotics overall increased with age, stimulants were mostly used by 6–16-year olds. The girl/boy ratio for any psychotropic medication use in RC was 1.4 (95% confidence interval [95% CI]: 1.1–1.6), significantly higher than the corresponding ratio in GenPop: 1.0 (95% CI: 0.9–1.0). Conclusion: The present findings do not necessarily suggest an overtreatment with medication in RC. However, the frequent short-term use of antipsychotics, presumably for non-psychotic symptoms, is a concern, as it may reflect that the youth are not provided with the recommended first-line psychological treatments.
format Online
Article
Text
id pubmed-8233215
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-82332152021-07-06 The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care Oerbeck, Beate Overgaard, Kristin Romvig Hjellvik, Vidar Lien, Lars Bramness, Jørgen G J Child Adolesc Psychopharmacol Original Articles Objectives: To assess the use of three commonly prescribed psychotropic medications in youth placed in residential care (RC). Methods: Participants were youth aged 0–20 years placed in RC institutions at least once during 2016. Data on filled prescriptions were taken from the Norwegian Prescription Database to compare the use of antidepressants, antipsychotics, and stimulants in RC with the age- and gender-adjusted general child population (GenPop) and how this co-varied with reasons for RC placement, age, and gender. Results: One thousand eight hundred fifty-six children and adolescents were identified in RC, with mean age 14 (range 0–20 years), 46% girls, 81% ≥ 13 years. Among those, 423 or 23% used any of the 3 psychotropics, which was significantly more than the 3.7% in GenPop. The prevalence ratios RC/GenPop were 6.6 for antidepressants, 17.9 for antipsychotics, and 4.4 for stimulants. The median number of days per year for the dispensed defined daily doses varied from 8.3 to 244.0 for the different antipsychotics, indicating short time use for most of the people. Polypharmacy was not frequent in RC, as only 26% used ≥2 classes of medication, but still significantly more frequent than the 10% in GenPop. Youth placed in RC for serious behavior problems had significantly higher use of stimulants than those with other placement reasons. Psychotropics were not used below age 6 years, and although the use of antidepressants and antipsychotics overall increased with age, stimulants were mostly used by 6–16-year olds. The girl/boy ratio for any psychotropic medication use in RC was 1.4 (95% confidence interval [95% CI]: 1.1–1.6), significantly higher than the corresponding ratio in GenPop: 1.0 (95% CI: 0.9–1.0). Conclusion: The present findings do not necessarily suggest an overtreatment with medication in RC. However, the frequent short-term use of antipsychotics, presumably for non-psychotic symptoms, is a concern, as it may reflect that the youth are not provided with the recommended first-line psychological treatments. Mary Ann Liebert, Inc., publishers 2021-06-01 2021-06-16 /pmc/articles/PMC8233215/ /pubmed/33635152 http://dx.doi.org/10.1089/cap.2020.0123 Text en © Beate Oerbeck et al. 2021; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by-nc/4.0/This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License [CC-BY-NC] (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are cited.
spellingShingle Original Articles
Oerbeck, Beate
Overgaard, Kristin Romvig
Hjellvik, Vidar
Lien, Lars
Bramness, Jørgen G
The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care
title The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care
title_full The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care
title_fullStr The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care
title_full_unstemmed The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care
title_short The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care
title_sort use of antidepressants, antipsychotics, and stimulants in youth residential care
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233215/
https://www.ncbi.nlm.nih.gov/pubmed/33635152
http://dx.doi.org/10.1089/cap.2020.0123
work_keys_str_mv AT oerbeckbeate theuseofantidepressantsantipsychoticsandstimulantsinyouthresidentialcare
AT overgaardkristinromvig theuseofantidepressantsantipsychoticsandstimulantsinyouthresidentialcare
AT hjellvikvidar theuseofantidepressantsantipsychoticsandstimulantsinyouthresidentialcare
AT lienlars theuseofantidepressantsantipsychoticsandstimulantsinyouthresidentialcare
AT bramnessjørgeng theuseofantidepressantsantipsychoticsandstimulantsinyouthresidentialcare
AT oerbeckbeate useofantidepressantsantipsychoticsandstimulantsinyouthresidentialcare
AT overgaardkristinromvig useofantidepressantsantipsychoticsandstimulantsinyouthresidentialcare
AT hjellvikvidar useofantidepressantsantipsychoticsandstimulantsinyouthresidentialcare
AT lienlars useofantidepressantsantipsychoticsandstimulantsinyouthresidentialcare
AT bramnessjørgeng useofantidepressantsantipsychoticsandstimulantsinyouthresidentialcare